| scholarly article | Q13442814 |
| P2093 | author name string | L Jackson Roberts | |
| Ray L Mernaugh | |||
| Joshua P Fessel | |||
| James West | |||
| Jennifer A Johnson | |||
| Tom Blackwell | |||
| Anna R Hemnes | |||
| Linda Robinson | |||
| Eric Austin | |||
| Megha Talati | |||
| Candice Fike | |||
| Kirk L Lane | |||
| P2860 | cites work | A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension | Q37702950 |
| Cross talk between Smad, MAPK, and actin in the etiology of pulmonary arterial hypertension | Q37702964 | ||
| Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury | Q39710554 | ||
| Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme | Q42119587 | ||
| Bringing down the ROS: a new therapeutic approach for PPHN. | Q43164191 | ||
| Oxidant stress but not thromboxane decreases with epoprostenol therapy | Q43772005 | ||
| Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension | Q46626780 | ||
| Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress | Q46937052 | ||
| BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension | Q47589236 | ||
| Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH. | Q51760564 | ||
| Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension | Q55670914 | ||
| A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases | Q73876065 | ||
| Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo | Q77150641 | ||
| Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension | Q81541147 | ||
| Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension | Q24298704 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer | Q24652941 | ||
| Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 | Q24675335 | ||
| GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies | Q24801173 | ||
| Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection | Q27860727 | ||
| Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia | Q28239012 | ||
| Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models | Q30487260 | ||
| The Gene Ontology in 2010: extensions and refinements | Q33600840 | ||
| In vivo measurement of proximal pulmonary artery elastic modulus in the neonatal calf model of pulmonary hypertension: development and ex vivo validation. | Q33783472 | ||
| Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress | Q33949978 | ||
| Detection of superoxide in vascular tissue | Q34993923 | ||
| Controlling cell fate by bone morphogenetic protein receptors. | Q35600636 | ||
| Alterations of cellular bioenergetics in pulmonary artery endothelial cells | Q35611704 | ||
| Isoketals: highly reactive gamma-ketoaldehydes formed from the H2-isoprostane pathway | Q35705122 | ||
| Insight into redox-regulated gene networks in vascular cells | Q35850434 | ||
| Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension | Q36009394 | ||
| NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions | Q36419639 | ||
| Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? | Q36634716 | ||
| Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes | Q36830217 | ||
| Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions | Q36977330 | ||
| Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. | Q36979666 | ||
| Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer | Q37033660 | ||
| Clinical review: The role of advanced glycation end products in progression and complications of diabetes | Q37053328 | ||
| Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies | Q37156415 | ||
| Structural implications of mitochondrial dynamics | Q37177420 | ||
| Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells | Q37216678 | ||
| Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension | Q37389602 | ||
| Targeting the Warburg effect in hematological malignancies: from PET to therapy | Q37545285 | ||
| Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials | Q37678455 | ||
| Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species | Q37685389 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 72-83 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Pulmonary circulation | Q26842412 |
| P1476 | title | Oxidative injury is a common consequence of BMPR2 mutations | |
| P478 | volume | 1 |
| Q37104263 | A potential role for insulin resistance in experimental pulmonary hypertension |
| Q38078369 | A process-based review of mouse models of pulmonary hypertension |
| Q38448103 | Accumulation of isolevuglandin-modified protein in normal and fibrotic lung |
| Q36908852 | Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload |
| Q35142695 | BMP pathway regulation of and by macrophages |
| Q35376926 | BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension |
| Q26786834 | BMPR2 spruces up the endothelium in pulmonary hypertension |
| Q36185917 | Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension |
| Q57070238 | Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells |
| Q36110556 | Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance. |
| Q35850232 | Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension |
| Q33738642 | Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension |
| Q36352101 | Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis |
| Q37596437 | Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. |
| Q34130859 | Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension. |
| Q35573948 | Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. |
| Q35941642 | Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension |
| Q33806083 | Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension |
| Q36108056 | Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming |
| Q38262569 | Novel serum biomarkers in pulmonary arterial hypertension |
| Q38642429 | Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects |
| Q50041340 | Oxidative stress increases M1dG, a major peroxidation-derived DNA adduct, in mitochondrial DNA. |
| Q35121379 | Physiologic and molecular consequences of endothelial Bmpr2 mutation |
| Q58998388 | Pulmonary Hypertension Is a Probable NO/ONOO− Cycle Disease: A Review |
| Q39419466 | Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension |
| Q26772286 | Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series) |
| Q35410950 | Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension |
| Q28078566 | Role of oxidized lipids in pulmonary arterial hypertension |
| Q35919662 | Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension |
| Q27000503 | The adventitia: essential regulator of vascular wall structure and function |
Search more.